United States
Germany
Japan
United Kingdom
China
Anti-CD166(praluzatamab biosimilar) mAb
| Applications | FC |
| Reactivities | Human |
Products
Anti-CD166 antibody(DMC682), IgG1 Chimeric mAb
| Applications | FC |
| Reactivities | Human |
Anti-CD166(praluzatamab biosimilar) mAb
| Applications | FC |
| Reactivities | Human |
Anti-CD166 antibody(DMC682), IgG1 Chimeric mAb
| Applications | FC |
| Reactivities | Human |
